Zhende Medical Co., Ltd. Class A 603301

SSE · China · Health Technology

CNY 75.17-0.63 (-0.83%)

Market closed· Sep 30, 2026, 7:00 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Zhende Medical Co., Ltd. Class A 603301

SSE · China · Health Technology

CNY 75.17-0.63 (-0.83%)

Market closed· Sep 30, 2026, 7:00 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-22.89% · 6MFull-screen chart

Open CNY 76.00High CNY 76.49Low CNY 74.09Close CNY 75.17Volume 1.39M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 75.80
Day range: CNY 74.09 – CNY 76.49
52-week range: CNY 46.66 – CNY 104.84
Volume: 1.39M
Market cap: CNY 19.68B
P/E (TTM): 71.6
Dividend yield (annualized): 0.40%
Next earnings date: 2026-10-30
Avg. volume (1Y): 4.97M

Performance

1 week

-7.14%

1 month

-7.99%

3 months

-10.55%

6 months

-17.75%

Year to date

+5.40%

1 year

+61.65%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Medical Specialties
Country: China
Exchange: SSE
Shares outstanding: 263.88M
Employees: 7,909
ISIN: CNE100003J31
Beta: 1.08

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceMay 21, 2026

Mölnlycke Health Care and Zhende Medical form pioneering joint venture to expand access to advanced wound care solutions in China

Mölnlycke Health Care ("Mölnlycke®"), a global leader in MedTech and advanced wound care solutions, and Zhende Medical, a leading supplier of medical care and protection in China, today announce the formation of a new joint venture company in China to accelerate growth in one of the world's fastest-growing wound care markets. The joint venture, majority-owned by Mölnlycke, will integrate the two companies' wound care portfolios and commercial capabilities to offer healthcare providers, patients

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.